L'BRI Klearaway

Manufacturer
L'BRI Health & Beauty | Pure Source, LLC
Effective date
2026-07-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
weekly-update
Hydrated at
2026-07-17 21:43:49

Label at a glance#

ProductL BRI Klearaway
Active ingredientSALICYLIC ACID
Label structure7 sections

Dosage and administration

Cleanse the skin thoroughly before applying medication. Shake tube vigorously until completely mixed. Dispense product onto cotton ball and swipe soaked pad onto blemishes. Because excessive drying of the skin may occur, start with one application nightly, or as directed by doctor. Avoid contact with eyes or mucous membranes.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2.0%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Use For:

INDICATIONS & USAGE SECTION

For the treatment of Acne. Helps clear up acne pimples and blemishes, and allows skin to heal. Helps prevent new pimples and blemishes from forming.

Warnings

WARNINGS SECTION

  •  For external use only.
  • Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once per day.
  • Do not use for prolonged periods without consulting a doctor.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, contact physician or poison control center immediately. 

Store at room temperature.

Directions

DOSAGE & ADMINISTRATION SECTION

Cleanse the skin thoroughly before applying medication. Shake tube vigorously until completely mixed. Dispense product onto cotton ball and swipe soaked pad onto blemishes. Because excessive drying of the skin may occur, start with one application nightly, or as directed by doctor. Avoid contact with eyes or mucous membranes.

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Allantoin, Aloe Barbadensis Leaf (Aloe Vera Gel) Juice, Aqua (Deionized Water), Carica Papaya Fruit Extract, Cetyl Alcohol, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Hydroxyethylcellulose, Magnesium Aluminium Silicate, Melaleuca Alternifolia (Tea Tree) Oil, PEG-100 Stearate, Phenoxyethanol, Salix Alba (Willow) Bark Extract, Sodium PCA, Stearic Acid, Tetrasodium EDTA, Triethanolamine, Zemea (Corn) Propanediol.

Package Labeling: 5ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label0Label0

Package Labeling: 177ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer PackageOuter PackageInner PackageInner Package

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 1281901Outer Package.jpg
Data codeCode 128S1901Label0.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71238-92271238-922-05, 71238-922-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
L BRI KlearawaySALICYLIC ACIDL'BRI Health & Beautyb9aa1c48-b767-47b0-bb98-efb7e860ab362026-07-06WarningsExact identifier
ndc (package): 71238-922-05
ndc (package): 71238-922-30
ndc (product): 71238-922
ndc11 (package): 71238092205
ndc11 (package): 71238092230
spl id: 55ef88ad-5d72-ca1a-e063-6394a90ad87e
spl set id: b9aa1c48-b767-47b0-bb98-efb7e860ab36

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.